1. Home
  2. WGS vs IART Comparison

WGS vs IART Comparison

Compare WGS & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo GeneDx Holdings Corp.

WGS

GeneDx Holdings Corp.

HOLD

Current Price

$87.07

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo Integra LifeSciences Holdings Corporation

IART

Integra LifeSciences Holdings Corporation

HOLD

Current Price

$16.74

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WGS
IART
Founded
2017
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Retail: Computer Software & Peripheral Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
2020
1996

Fundamental Metrics

Financial Performance
Metric
WGS
IART
Price
$87.07
$16.74
Analyst Decision
Strong Buy
Hold
Analyst Count
7
7
Target Price
$120.71
$14.33
AVG Volume (30 Days)
750.4K
833.3K
Earning Date
05-04-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
62.37
N/A
EPS
N/A
N/A
Revenue
$427,539,000.00
N/A
Revenue This Year
$29.98
$4.39
Revenue Next Year
$25.92
$3.40
P/E Ratio
N/A
N/A
Revenue Growth
39.97
N/A
52 Week Low
$32.21
$8.70
52 Week High
$170.87
$20.49

Technical Indicators

Market Signals
Indicator
WGS
IART
Relative Strength Index (RSI) 69.46 43.30
Support Level $81.55 $16.04
Resistance Level $96.34 $18.78
Average True Range (ATR) 5.31 0.64
MACD 0.70 -0.10
Stochastic Oscillator 99.79 17.69

Price Performance

Historical Comparison
WGS
IART

About WGS GeneDx Holdings Corp.

GeneDx Holdings Corp focuses on genomics, creating the foundation for providing genomic information at scale and pioneering exome and genome sequencing for rare and ultra-rare genetic pediatric disorders. The company believes exome and genome testing will become the standard for diagnosing genetic disease, with the potential to transform healthcare from reactive to proactive. It aims to advance precision medicine by offering genetic diagnoses at the earliest moments, driving improved outcomes, and fueling discovery with genomic intelligence. Its operating segment mainly provides pediatric and rare disease diagnostics, focusing on whole exome and genome sequencing and, to a lesser extent, data and information services.

About IART Integra LifeSciences Holdings Corporation

Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.

Share on Social Networks: